Inventor
MARING CLARENCE J
US38 patents
⚠️ This page may combine multiple inventors who share the name “MARING CLARENCE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
11 patentsUS5468769ANov 21, 1995
Paclitaxel derivatives
ABBOTT LAB53 citations96
US6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US7910595B2Mar 22, 2011
Anti-viral compounds
ABBOTT LAB18 citations83
US5140014AAug 18, 1992
Rosaramicin derivatives and method of treating bacterial infections
ABBOTT LAB14 citations73
US6593314B1Jul 15, 2003
Neuraminidase inhibitors
ABBOTT LAB8 citations71
US6518305B1Feb 11, 2003
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ABBOTT LAB6 citations62
US5075289ADec 24, 1991
9-r-azacyclic erythromycin antibiotics
ABBOTT LAB5 citations62
US7915411B2Mar 29, 2011
Anti-viral compounds
ABBOTT LAB3 citations61
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US7951800B2May 31, 2011
Anti-infective agents
ABBOTT LAB0 citations52
US7902203B2Mar 8, 2011
Anti-infective agents
ABBOTT LAB0 citations39
ABBVIE INC
10 patentsUS9006387B2Apr 14, 2015
Anti-viral compounds
ABBVIE INC4 citations72
US9139536B2Sep 22, 2015
Anti-infective agents and uses thereof
ABBVIE INC2 citations62
US9095590B2Aug 4, 2015
Anti-infective agents and uses thereof
ABBVIE INC3 citations62
US9637478B2May 2, 2017
Antiviral compounds and uses thereof
ABBVIE INC0 citations52
US9353091B2May 31, 2016
Antiviral compounds and uses thereof
ABBVIE INC0 citations52
US10039754B2Aug 7, 2018
Anti-viral compounds
ABBVIE INC0 citations51
US10028937B2Jul 24, 2018
Anti-viral compounds
ABBVIE INC0 citations51
US9586978B2Mar 7, 2017
Anti-viral compounds
ABBVIE INC0 citations51
US9567355B2Feb 14, 2017
Hepatitis C inhibitors and uses thereof
ABBVIE INC0 citations51
US9453007B2Sep 27, 2016
Hepatitis C inhibitors and uses thereof
ABBVIE INC0 citations51
WAGNER ROLF
3 patentsDEGOEY DAVID A
3 patentsUPJOHN CO
3 patentsUS4467103AAug 21, 1984
Processes for the preparation of spectinomycin analogs, products and intermediates therein
UPJOHN CO2 citations63
US4698436AOct 6, 1987
Processes for the preparation of spectinomycin analogs, novel products and intermediates therein
UPJOHN CO0 citations42
US4542227ASep 17, 1985
Processes for the preparation of spectinomycin analogs, novel products and intermediates therein
UPJOHN CO0 citations42